Home > Subject >

Sodium-glucose cotransporter 2 inhibitors

SGLT-2 Inhibitors and DKA

Heather Saran and Kathleen Wyne, M.D., Ph.D.
Volume 32, Number 2, pages 12-14

SGLT-2 Inhibitors and Glucose Homeostasis

Kathleen Wyne, M.D., Ph.D.
Volume 35, Number 3, pages 16-19

Should SGLT2 Inhibitors Be Used to Treat Type 1 Diabetes?

Kathleen Wyne, MD, PhD, Associate Professor, Division of Endocrinology, Diabetes and Metabolism The Ohio State University, Wexner Medical Center Columbus, Ohio
Volume 36, Number 3, pages 2-6

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Type 2 Diabetes

Muhammad A. Abdul-Ghani, M.D., Ph.D., and Ralph A. DeFronzo, M.D.
Volume 30, Number 2, pages 6-14

The Cadillac Combination for Type 2 Diabetes: A GLP-1 receptor Agonist and a SGLT2 Inhibitor

David S. H. Bell, MB, FACE, FACP Professor of Medicine (retired) University of Alabama and Southside Endocrinology Birmingham, Alabama, and Edison Goncalves, MD, FACE, FACP Diabetes and Thyroid Associates Birmingham, Alabama
Volume 36, Number 3, pages 10-13